The purpose of this study was to observe heart rate and respiration responses to real traffic pattern flight. Nine experienced and nine less-experienced military pilots on active flying status participated in four uninterrupted traffic patterns flight missions with F-7 jet trainer. The heart rates and respiration waves were continuously recorded using a small recording device strapped around the chest. As compared with baseline values, significant increases in heart rates of the two groups (for experienced pilots group, F (11, 88) = 4.636, p = 0.000; for less-experienced, F (11, 88) = 4.437, p = 0.000) and mean respiration rates of less-experienced group (F (11, 88) = 4.488, p = 0.000) were obtained during the phases of take-off, final approach and landing. Heart rates of less-experienced pilots were significant higher than those of experienced pilots during the take-off phase (p < 0.05). There were no significant differences in respiration rates between the two groups at each phase of the whole flight. The results show that take-off, final approach and landing are the most mental workload phases in-flight, and less-experienced pilots show more mental workload than experienced pilots in take-off phase in-flight.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10484-008-9066-x | DOI Listing |
Clin Lung Cancer
December 2024
Department of Thoracic Surgery, Liverpool Heart and Lung Hospital, Liverpool, UK.
Background: To evaluate the real-world surgical and pathological outcomes following neoadjuvant nivolumab in combination with chemotherapy in a multicentre national cohort of patients.
Methods: Retrospective analysis on consecutive patients treated in three tertiary referral hospitals in UK with neoadjuvant chemotherapy and immunotherapy (nivolumab) for stage II-IIIB nonsmall cell lung cancer (March 2023-May 2024). Surgical and pathological outcomes were assessed.
J Card Fail
January 2025
Cardiology providers and healthcare clinicians tackling heart failure (HF) face an escalating challenge: rising prevalence rates and widening disparities among populations. In this context, leveraging up-to-date and specialized data becomes paramount. Although the American Heart Association's (AHA) Heart and Stroke Statistics provides a sweeping overview of cardiovascular health with a few pages dedicated to HF and cardiomyopathy, the Heart Failure Society of America's (HFSA) HF Stats annual publication offers an up-to-date and in-depth look at multiple themes related to HF epidemiology, global trends, outcomes and much more.
View Article and Find Full Text PDFJ Cardiol
January 2025
Department of Cardiology, St. Luke's University Health Network, Bethlehem, PA, USA. Electronic address:
Background: Hypertrophic cardiomyopathy (HCM) is a common genetic disease with estimated prevalence of 0.2-0.5 %.
View Article and Find Full Text PDFJ Cardiol
January 2025
Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan. Electronic address:
Background: Despite increasing awareness in general practice, heart failure with preserved ejection fraction (HFpEF) remains under-diagnosed in the community due to diagnostic difficulties. Dedicated dyspnea clinics are responsible for diagnosing HFpEF and efficient referral from primary care physicians is the key to enhance its role.
Methods: This retrospective analysis was performed to assess the effectiveness of a one-year collaborative project between our dyspnea clinic and the Maebashi Medical Association.
J Am Soc Echocardiogr
January 2025
Cardiology Clinic, University Center Serbia, Medical School, University Clinical Center Serbia, University of Belgrade, Serbia.
Background: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous entity including patients with different phenotypes of near normal, normal, and supernormal left ventricular (LV) function.
Objectives: To assess the value of resting LV elastance (also known as force) with transthoracic echocardiography (TTE) to identify HFpEF phenotypes.
Methods: In a prospective, observational, multicenter study, 2380 HFpEF patients were recruited from July 2016 to May 2024.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!